Madurna vs Fizer

Gerard holts: It's tough to be a biotec analyst these days, when you get an analyst sayng. If they don't like the first layer of this group, or the large cap names in this group, i think it's a low probability event that they're going to want to peek under the hood and kick stocks thatare that ar smaller. Gerard Holts: I understand why some investors continue to gravitate toward maderna. There is a simplicity factor to madurna that i think makes it attractive over the near term. And i actually like the ex b i more because it's come in more.